20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
InMode Ltd (INMD) operates in the MEDICAL DEVICES industry and is headquartered in Yokne'am, Israel with about 660 employees. Its market capitalization is roughly $826 million. In the fiscal year ended 2025-12-31, INMD reported $370M in revenue and $94M in net income.
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.
Interactive charts & full statements → Open the INMD valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $375M | $370M | $395M | $492M | $454M | $358M | $206M | $156M | $100M | $53M | $23M |
| Gross Profit | $287M | $291M | $317M | $411M | $381M | $304M | $175M | $136M | $85M | $44M | $17M |
| Gross Margin % | 76.5% | 78.5% | 80.3% | 83.6% | 83.8% | 85.0% | 85.0% | 87.1% | 85.0% | 83.1% | 75.5% |
| Operating Income (EBIT) | $69M | $85M | $113M | $196M | $198M | $167M | $73M | $60M | $23M | $9M | $1M |
| Operating Margin % | 18.5% | 23.1% | 28.5% | 39.8% | 43.5% | 46.8% | 35.3% | 38.1% | 23.4% | 16.7% | 2.9% |
| Net Income | $78M | $94M | $181M | $198M | $162M | $165M | $75M | $61M | $22M | $9M | $0M |
| Net Margin % | 20.7% | 25.3% | 45.9% | 40.2% | 35.6% | 46.1% | 36.4% | 39.1% | 22.3% | 16.5% | 1.5% |
| EBITDA | $84M | $111M | $144M | $218M | $202M | $169M | $73M | $60M | $32M | $9M | $1M |
| Earnings Per Share (EPS) | $1.23 | $1.43 | $2.25 | $2.30 | $1.89 | $1.92 | $0.89 | $0.80 | $0.35 | $0.14 | $0.01 |
| Shares Outstanding (M) | 59M | 65M | 81M | 86M | 85M | 86M | 84M | 76M | 64M | 64M | 53M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $96M | $82M | $104M | $93M | $96M | $78M | $98M | $130M |
| Gross Profit | $72M | $62M | $81M | $72M | $76M | $61M | $78M | $106M |
| Gross Margin % | 74.8% | 75.0% | 78.3% | 77.6% | 80.0% | 78.2% | 79.3% | 81.5% |
| Operating Income (EBIT) | $12M | $10M | $26M | $21M | $23M | $16M | $28M | $48M |
| Operating Margin % | 12.8% | 12.3% | 25.0% | 22.4% | 23.9% | 20.1% | 28.5% | 37.1% |
| Net Income | $17M | $12M | $27M | $22M | $27M | $18M | $83M | $51M |
| Net Margin % | 17.8% | 14.1% | 26.0% | 23.5% | 28.0% | 23.4% | 84.6% | 39.1% |
| EBITDA | $12M | $15M | $31M | $26M | $31M | $23M | $32M | $48M |
| Earnings Per Share (EPS) | $0.29 | $0.18 | $0.42 | $0.34 | $0.42 | $0.26 | $1.14 | $0.65 |
| Shares Outstanding (M) | 59M | 64M | 64M | 64M | 64M | 69M | 73M | 79M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $89M | $85M | $133M | $177M | $182M | $175M | $79M | $62M | $37M | $15M | $3M |
| Capital Expenditures (CapEx) | $1M | $1M | $1M | $1M | $2M | $1M | $0M | $1M | $0M | $0M | $0M |
| Free Cash Flow (FCF) | $87M | $84M | $132M | $176M | $180M | $174M | $79M | $62M | $37M | $14M | $3M |
| FCF Margin % | 23.3% | 22.8% | 33.4% | 35.8% | 39.6% | 48.6% | 38.2% | 39.3% | 36.4% | 27.0% | 12.2% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $21M | $15M | $25M | $27M | $24M | $14M | $32M | $34M |
| Capital Expenditures (CapEx) | $0M | $0M | $1M | $0M | $0M | $0M | $0M | $0M |
| Free Cash Flow (FCF) | $21M | $15M | $24M | $27M | $24M | $14M | $32M | $34M |
| FCF Margin % | 21.8% | 18.6% | 23.5% | 29.0% | 25.1% | 17.9% | 32.9% | 26.1% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $720M | $766M | $786M | $863M | $644M | $479M | $296M | $218M | $81M | $39M | $16M |
| Cash & Cash Equivalents | $396M | $303M | $155M | $144M | $98M | $68M | $69M | $45M | $25M | $18M | $7M |
| Total Liabilities | $91M | $83M | $82M | $76M | $90M | $63M | $40M | $39M | $36M | $20M | $7M |
| Total Debt (Short + Long-Term) | $0M | $3M | $3M | $2M | $1M | $1M | $1M | $1M | $0M | $3M | $0M |
| Total Shareholders' Equity | $629M | $683M | $704M | $787M | $555M | $416M | $254M | $176M | $43M | $19M | $9M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive INMD viewer.
About TickerBase · Data methodology & sources · Privacy · Terms